Sandoz Launches Slovenian Facility, Opening Doors for Skilled Talent
Sandoz, the global leader in generic and biosimilar medicines, announced the start of construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia. This USD 440 million project brings the company’s total planned and ongoing investment in Slovenia to more t…
